Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share Price (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.19    -0.005 (-2.56%)
Bid:
0.18
Ask:
0.20
Spread: 0.02 (11.111%)
Market Cap: £1.41m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

ValiRx Share Price
Price 0.19 Open 0.195
Bid 0.18 High 0.195
Ask 0.20 Low 0.19
Change -0.005 (-2.56%) Close 0.195
Volume 7,587,343
Currency GBX
Issue Country GB
Shares in Issue 742.80m
Market Cap £1.41m
PE Ratio -0.131034
EPS -1.45
Year High 0.80
Year High Date 20-Jun-2025
Year Low 0.19
Year Low Date 19-May-2026
Dividend 0.00
Yield 0.00%
# Trades 22
Vol. Sold 110,656
Sold Value £N/A
Vol. Bought 2,640,480
Bought Value £5.20k
Market Size 1,000,000
What if I invested £1,000 in ValiRx?
£ 655.17 (-34.48%)
1 month ago
£ 593.75 (-40.63%)
3 months ago
£ 808.51 (-19.15%)
6 months ago
£ 361.90 (-63.81%)
1 year ago
Add VAL to WatchlistAdd VAL to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Valirx Plc Ord 0.1p

ValiRx is listed in the FTSE AIM All-Share index.

ValiRx is listed in the Medicine and Biotech sector.

Valirx Plc Ord 0.1p is listed on the London Stock Exchange trading with ticker code VAL.L. It has a market capitalisation of £1.41m, with approximately 742.80m shares in issue. Over the last year, ValiRx share price has been traded in a range of 0.61, hitting a high of 0.80, and a low of 0.19.

VALIRX plc, a British biotechnology company, focuses on the development of innovative treatments for cancer and other related disorders. Through rigorous research and clinical trials, VALIRX aims to advance novel therapeutic solutions that target specific disease mechanisms. Committed to improving patient outcomes, the company's cutting-edge approach encompasses precision medicine and personalised treatment strategies. VALIRX's pursuit of scientific excellence and medical advancement underscores its dedication to addressing critical healthcare challenges in the UK and beyond.

Some Videos You Might Like

What's Hot end of April


 

What's Hot 8th April 2026


Recent Share Trades for ValiRx (VAL)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
19-May-2615:23:000.20750Buy*0.180.201.50O Ordinary
19-May-2614:20:370.18353,790,291Unknown*0.180.206,955O Ordinary
Delayed publication
19-May-2613:37:510.1835100,000Sell*0.180.20183.50O Ordinary
19-May-2611:56:220.196892,882Buy*0.180.201,750O Ordinary
19-May-2611:49:560.196100,000Buy*0.180.20196.00O Ordinary
19-May-2611:39:250.1968250,000Buy*0.180.20492.00O Ordinary
19-May-2610:41:310.19767,538Buy*0.180.20133.05O Ordinary
19-May-2610:20:270.191,000,000Unknown*0.180.201,900O Ordinary
19-May-2610:20:330.205,650Buy*0.180.2011.30O Ordinary
Trade was executed as an SI
19-May-2610:16:240.1975502,810Buy*0.190.20993.05O Ordinary

Directors Deals for ValiRx (VAL)

Announced Traded Action Notifier Price Currency Amount Holding
04-Mar-2603-Mar-26BuyMark Eccleston held the position of Chief Executive Officer at the time of this trade.Mark Eccleston0.33GBX1,000,0000
07-Jul-2207-Jul-22PlacingKevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox10.00GBX100,000372,333
07-Jul-2207-Jul-22PlacingSuzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly10.00GBX100,000416,668
07-Jul-2207-Jul-22PlacingGerald Desler held the position of CFO at the time of this trade.Gerald Desler10.00GBX25,000128,668
07-Jul-2207-Jul-22PlacingMartin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire10.00GBX100,000144,000